New meta-analyses, the first ESC consensus document on mental health and heart disease and groundbreaking Lancet dataon antidepressant drugs show: Depression is an independent, quantifiable and treatable risk factor for cardiovascular death – and it is systematically underestimated in cardiology practice. Cardiovascular disease is the leading cause of death worldwide; according to WHO data, depression is one of the leading causes of disability and years of life lost. Both diseases do not co-exist by chance: a meta-analysis published in World Psychiatry in October 2025 with 268 cohort studies and over 10 million depression patients puts the overall mortality risk at 2.1 times that of the general population – and shows that cardiovascular mortality is particularly prominent with a relative risk of 1.63 for natural causes of death. In November 2025, the European Heart Journal published the first ESC Clinical Consensus Statement on mental health and heart disease.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Actinic keratoses
Targeted Treatment of Multiple AK Lesions—Balancing Efficacy and Convenience
- Obesity: A Multimodal and Interdisciplinary Approach
New Swiss Clinical Practice Guideline Provides Guidance
- cSCC: Personalizing Treatment Strategies and Follow-up Care Plans
Comprehensive risk stratification is no simple matter: what’s new?
- Baxdrostat – a new class of drugs for treating difficult-to-control hypertension
First Aldosterone Synthase Inhibitor Is Here
- Geriatric Small-Cell Lung Cancer
Therapeutic Challenges
- Chronic Pruritus in Renal, Hepatic, and Biliary Tract Diseases
Pooled Expertise for Targeted Evaluation and Treatment
- Advanced Thyroid Cancer
Molecular Mechanisms and New Therapeutic Approaches
- Epidermolysis bullosa